Selective Defunctioning Stoma in Low Anterior Resection for Rectal Cancer
SELSA
SELective Defunctioning Stoma Approach in Low Anterior Resection for Rectal Cancer (SELSA): a Prospective Study With a Nested Randomised Clinical Trial
1 other identifier
interventional
212
1 country
1
Brief Summary
The goal of this observational trial with a nested randomized controlled trial is to investigate a selective approach of defunctioning stoma in low anterior resection in rectal cancer patients. The primary outcome is a hybrid so-called textbook outcome; stoma-free survival at two years without major LARS, reflecting a functionally appropriate outcome after low anterior resection for rectal cancer. Secondary outcomes include anastomotic leakage, postoperative mortality, reinterventions, stoma-related complications, quality of life measures, LARS, and permanent stoma rate up to two years after index surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2023
CompletedFirst Posted
Study publicly available on registry
January 22, 2024
CompletedStudy Start
First participant enrolled
September 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
May 21, 2025
May 1, 2025
3.3 years
December 17, 2023
May 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
textbook outcome; stoma-free survival at two years without major LARS
extant stoma, alive, and a LARS score at 30 or lesn has stabilised as well for those without a stoma in situ. no extant stoma, alive, and a LARS score at 30 or less at the time point two years after the anterior resection.
2 year
Secondary Outcomes (14)
Anastomotic leakage
1,3,12 and 24 months
Complications
1,3,12 and 24 months
Length of hospital stay
until discharge within 90 days
Postoperative mortality
3 months
Major Low Anterior Resection Syndrome
12 and 24 months
- +9 more secondary outcomes
Study Arms (2)
selective approach to defunctioning stoma
EXPERIMENTALWith randomisation to this experimental arm (selective approach), no defunctioning stoma is constructed.
routine use of defunctioning stoma
NO INTERVENTIONWith randomisation to this control arm (systematic approach), a defunctioning stoma is constructed using the marked stoma site. A loop ileostomy is fashioned using an ileal loop close to the ileocecal valve, while a loop colostomy can be derived from either the transverse or a redundant left colon.
Interventions
With randomisation to this experimental arm (selective approach), no defunctioning stoma is constructed.
Eligibility Criteria
You may qualify if:
- Adult patients with rectal cancer planned for a low anterior resection with anastomosis by TME with any surgical approach
- Patients aged less than 80 years
- Patients with American Society of Anesthetists' (ASA) fitness grade I or II as determined by the anaesthesiologist or the surgeon
- Anastomotic leak risk score of 0-1
- Willingness to be randomised
You may not qualify if:
- Insufficient command of Swedish, Norwegian, Danish or English to understand questionnaires or consent
- Emergency rectal resection (tumour resection due to large bowel obstruction, perforation, etc)
- Previous pelvic irradiation (due to e.g. gynaecological or urological cancer)
- Preoperative tumour perforation or pelvic sepsis
- Beyond TME surgery and/or concurrent resection of other organ
- Concurrent corticosteroid treatment (prednisone-equivalent dosage ≥10 mg daily)
- Planned postoperative chemotherapy
- Smoking not completely ceased four weeks before surgery
- \>2 staple firings for rectal transection
- Intraoperative blood loss ≥250 ml for minimally invasive surgery
- Intraoperative blood loss ≥500 ml for open or converted surgery
- More than one intraabdominal anastomosis performed
- Incomplete doughnuts
- Air-leak test positive
- Any significant intraoperative adverse event at the discretion of the operating surgeon (e.g. ureterotomy, bowel or tumour perforation, major medical event - pulmonary embolism, cardiac arrhythmia) (Gawria, 2022)
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Skane University Hospitallead
- Umeå Universitycollaborator
- Lund Universitycollaborator
- Göteborg Universitycollaborator
- Ersta Hospital, Swedencollaborator
- Copenhagen University Hospital at Herlevcollaborator
- Linkoeping Universitycollaborator
- Oslo University Hospitalcollaborator
- Örebro University, Swedencollaborator
Study Sites (1)
Skåne University Hospital
Malmo, Sweden
Related Publications (1)
Rutegard M, Lindskold M, Jorgren F, Landerholm K, Matthiessen P, Forsmo HM, Park J, Rosenberg J, Schultz J, Seeberg LT, Segelman J, Buchwald P. SELective defunctioning Stoma Approach in low anterior resection for rectal cancer (SELSA): Protocol for a prospective study with a nested randomized clinical trial investigating stoma-free survival without major LARS following total mesorectal excision. Colorectal Dis. 2025 Feb;27(2):e70009. doi: 10.1111/codi.70009.
PMID: 39887540DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pamela Buchwald, MD PhD
Skåne University Hospital, Lund University
- PRINCIPAL INVESTIGATOR
Martin Rutegård, MD PhD
Umeå University Hospital, Umeå University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate professor, senior consultant surgeon
Study Record Dates
First Submitted
December 17, 2023
First Posted
January 22, 2024
Study Start
September 1, 2024
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2030
Last Updated
May 21, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- When study complete including primary and secondary endpoints.
Unidentified raw data may be shared upon request.